Refine Results
- view as grid
- view as list
Litigation Challenging Title X Regulations
This brief provides an overview of the legal challenges to the Trump Administration final Title X regulations and summarizes the key positions of the plaintiffs and HHS.
Issue Brief Read More
Testimony: The U.S. Government Role in Women’s Global Health and Key Challenges
Jennifer Kates, Senior Vice President and Director of KFF’s Global Health & HIV Policy program, testified before the U.S. House of Representatives’ Committee on Foreign Affairs as part of a hearing on Unique Challenges Women Face in Global Health. Her testimony describes the role of the U.S. government in women’s global health and highlights challenges and opportunities to strengthen these efforts.
Issue Brief Read More
Analysis of Federal Bills to Strengthen Maternal Health Care
The bills in this table address a number of related maternity care issues, including extending Medicaid postpartum coverage from 60 days to one year, funding for clinical training on health equity and implicit bias, developing broader networks of maternity care providers in rural areas, and research on the potential benefits of Medicaid coverage for doula care.
Fact Sheet Read More
Briefing on Access to Reproductive Health Care for Low-Income Women in Five Communities
As policy debates over the future of access to reproductive and sexual health services heat up at the national and state levels, understanding how these policies are playing out on the ground requires getting beyond the statistics. Earlier this year, KFF, working with Health Management Associates, conducted case studies and…
Event Read More
A New Analysis Takes a Closer Look at Online Contraception Platforms Amid the Pandemic
Even prior to the COVID-19 pandemic, hormonal contraception became more accessible to many outside of traditional clinical settings through websites or apps that offer contraception via telehealth. To better understand this emerging method of contraceptive access, a new KFF analysis provides a deeper look at telecontraception platforms, offering insights into…
News Release Read More Two Women’s Health Policy Issues to Monitor in 2021
With President-elect Joe Biden and a new Congress taking office next month, newly updated KFF briefs examine two women’s health policy issues awaiting federal policymakers in 2021. President-elect Biden campaigned on reversing the Trump Administration’s regulations for the Title X family planning program, which require complete financial and physical separation…
News Release Read More
New Title X Regulations: Implications for Women and Family Planning Providers
This brief reviews the Trump Administration’s new final Title X family planning regulations, compares them to the current program rules and discusses the implications of these changes for low-income women seeking family planning services and the providers that have been serving them with Title X support
Issue Brief Read More
Web Briefing: The Sexual and Reproductive Health Landscape in the US: Current Trends and the Impact of the Pandemic
At 12:30 p.m. ET on Wednesday, April 21, KFF will hold a web briefing to highlight key findings on sexual and reproductive health from KFF’s national Women’s Health Survey. The presentation will be followed by a discussion with leaders in sexual and reproductive care about what those findings mean for policy and practice, how the pandemic has begun to reshape the provision of sexual and reproductive health care, and implications for the future of the family planning safety net and the people who rely on it.
Event Read More
Donor Government Funding for Family Planning in 2020
In 2020, donor government funding for family planning activities totaled US$1.40 billion, a decline of more than US$100 million compared to the 2019 amount (US$1.52 billion).
Report Read More
Minimum Contraceptive Coverage Requirements Clarified by HHS Guidance
New HHS clarification on ACA contraceptive coverage requirement specifies that insurance plans must cover at no cost to women all of the 18 contraceptive methods approved by the FDA. If a provider recommends a specific option or product, plans must cover it at no cost as well. Minimum Contraceptive Coverage…
Issue Brief Read More